KATIE OLSON: Open Payments
NPI 1407406051 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 18 payments from 8 companies in 2025. Trend: 2023 $559 · 2024 $338 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $97 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $89 |
| Optinose US, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| GENZYME CORPORATION | 2 | $32 |
| Organon LLC | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: NEFFY, DUPIXENT, NUCALA, Xhance, FASENRA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
